Physician

Aleem A Syed, MD

According to 2025 Medicare claims, Aleem Syed, MD (NPI: 1003828641) practices endocrinology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is ALEEM SYED MD A PROFESSIONAL CORPORATION (NPI: 1609972256; TIN: 04-3654536) and primary practice location at 92821-2606.

Syed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 392 traditional Medicare patients, billed 3,387 HCPCS/CPT codes, and received $210,581 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,280 prescription claims across 612 beneficiaries totaling $1,582,016 in drug costs, led by Ozempic (Semaglutide). DME data shows 164 claims. Open Payments data shows 104 records totaling $2,277. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $298,155 to $210,581. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,118,053 to $1,582,016. For DME billing, this smaller-volume category moved sharply higher in recent years, from $7,800 to $52,356.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	468	3,722	$298,155
2016	540	3,728	$299,622
2017	554	4,038	$315,267
2018	506	4,206	$290,033
2019	515	3,394	$248,647
2020	415	2,339	$175,852
2021	396	2,762	$213,588
2022	332	3,234	$226,882
2023	322	2,797	$198,571
2024	392	3,387	$210,581

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	512	4,260	$1,118,053
2016	554	3,953	$1,094,264
2017	615	4,628	$1,450,253
2018	710	4,896	$1,688,897
2019	838	6,100	$2,149,655
2020	754	5,601	$1,996,947
2021	819	5,845	$2,388,790
2022	813	5,626	$2,656,132
2023	653	4,543	$2,101,718
2024	612	4,280	$1,582,016

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	100	304	$8,194
2016	101	266	$4,027
2017	117	318	$3,857
2018	114	282	$3,575
2019	112	307	$3,785
2020	105	291	$7,982
2021	70	221	$11,311
2022	87	217	$22,056
2023	79	267	$40,244
2024	40	164	$46,210

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	135	143	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	218	422	$103
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	122	152	$98
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	126	562	$64
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	99	1,815	$41

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	194	9,772	$315,462
Jardiance	Empagliflozin	234	16,043	$305,238
Trulicity	Dulaglutide	168	6,920	$229,010
Januvia	Sitagliptin Phosphate	66	3,720	$64,541
Farxiga	Dapagliflozin Propanediol	39	2,672	$49,243

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	23	98	$41,573
E0784	External ambulatory infusion pump, insulin	Y	N/R	12	$4,030
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	17	39	$594
A4259	Lancets, per box of 100	N	N/R	15	$13

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	104	$2,277	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aleem A. Syed, MD?

Tedicare shows public-source Medicare data for Aleem A. Syed, MD (NPI 1003828641), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aleem A. Syed, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aleem A. Syed, MD?

Aleem A. Syed, MD is linked to ALEEM SYED MD A PROFESSIONAL CORPORATION (billing NPI 1609972256) in the available physician profile data.

Does Aleem A. Syed, MD have Open Payments data?

Aleem A. Syed, MD has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.